قالب وردپرس درنا توس
Home / Business / Dr. Scott Gottlieb said that the United States was only at the ‘tip of the slope’ of the coronavirus pandemic

Dr. Scott Gottlieb said that the United States was only at the ‘tip of the slope’ of the coronavirus pandemic



Dr. Scott Gottlieb warns that the United States is only “at the beginning of the epidemic” when coronavirus infections and hospital admissions across the country break gritty records.

In an interview on CNBC’s “The News with Shepard Smith” on Friday, the former FDA director said, “You’ll see cases start to accelerate in the coming weeks, I think the real inflection point will be. Thanksgiving.”

The US hit 9 million confirmed cases of virus infections on Friday, more than any other country. Thursday marks a one-day record by recording 90,456 new cases, according to the latest NBC News statistics. As for context, that̵

7;s more than one new instance per second. Gottlieb explained that this increase is more plausible nationwide, as opposed to earlier this year when it was first concentrated in New York and then in the South.

“The reason why it doesn’t feel bad in most parts of the country right now is because it’s in moderation everywhere,” said Gottlieb.

In Illinois, cases have skyrocketed to more than 6,900 a day, according to Johns Hopkins. It more than tripled the amount of what was added a month ago and caused new restrictions in Chicago. Starting Friday, bar service and dining have been banned to curb the spread of the virus.

Gottlieb told host Shepard Smith that the country could be licensed for a vaccine for a high-risk population at some point this year, but he noted that “you won’t have immune protection until 2021, because you need two doses of the vaccine and it needs to be infused about a month apart. “

As for the general public, however, Gottlieb said he doesn’t think there will be a licensed vaccine for widespread use until Q2 or Q3 2021.

For more on Shepard Smith’s interview with Dr. Scott Gottlieb, check out the full interview above.

Disclosure: Scott Gottlieb is a contributor to CNBC and a board member for Pfizer, gene testing startup Tempus, and biotech company Illumina. Pfizer has a manufacturing agreement with The gilead shirt for remdesivir. Gottlieb is also co-chair of Norwegian Cruise Line Holdings′ And Royal Caribbean“Sane Sails Dashboard.”


Source link